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Despite the extensive coordination chemistry of imidazoles, 
metal-mediated imidazole activation is very rare.[1] It has been 
shown that deprotonation of the central C-H group of coordinated 
N-alkylimidazoles can serve, after reaction of the resulting 
imidazolyl intermediate with an electrophile, as a new synthetic 
route to N-heterocyclic carbene (NHC) complexes.[2,3] NHC 
ligands, which attract much ongoing interest, have been compared 
to tertiary phosphanes, although it has been shown that NHCs can 
participate in C-H or C-C activation of N-alkyl or N-aryl 
substituents,[4] and, occasionally, adopt abnormal binding 
modes.[5] We have found that the outcome of the deprotonation of 
coordinated N-alkylimidazoles dramatically depends on the nature 
of the imidazole substituent and the ancillary ligands, and in some 
examples C-C coupling products are obtained instead of NHC 
complexes.[3a,b, 6] Even highly inert ligands, such as 2,2-
bipyridine,[6] or additional N-alkylimidazoles,[3a,b] afforded C-C 
coupling products, presumably reflecting a high nucleophilic 
character of the deprotonated species. Here we report the 
extension of our studies to [Re(CO)3(N-MeIm)2(PR3)]BAr’4 (N-
MeIm= N-methylimidazole; Ar’= 3,5-bis(trifluoromethyl)phenyl) 
compounds, showing that the nature of the phosphane substituents 
crucially determines the type of product. For the 
triphenylphosphane derivative, treatment with excess of base 
followed by MeOTf leads to an unprecedented double activation 
of the N-alkylimidazole ligand. The product, a binuclear complex, 
features a bridging ligand that is both an abnormal NHC and a 
Fischer carbene. 
[Re(CO)3(N-MeIm)2(PR3)]BAr’4 (R= Me, 1; Ph 2) 
compounds were prepared in good yields by substitution of the 
triflate ligand by the tertiary phosphane, assisted by the salt 
NaBAr’4. Compounds 1 and 2 were spectroscopically 
characterized and the solid-state structure of 2 was determined by 
X-ray diffraction.[7, 8] 
The reaction of 1 with KN(SiMe3)2 in THF at -78 °C afforded 
immediately the deprotonation of the central C-H group of an N-
MeIm ligand, as shown by a large shift to lower wavenumbers in 
the IR νCO bands (from 2034, 1938 and 1912 cm-1 to 1999, 1899 
and 1877 cm-1). The NMR data in solution are in accordance with 
the formation of the imidazol-2-yl complex 1a[7] as a result of 
changing the coordination mode of the heterocyclic ligand (from 
N- to C- rhenium bonded) upon deprotonation (Scheme 1). 
Imidazol-2-yl complexes are very reactive, and only in a few 
cases have been isolated.[1d-f, 3] 
 
Scheme 1. Reactivity of compound 1. 
Compound 1a was methylated at the non-substituted nitrogen 
to afford the NHC complex 1b (see Scheme 1). The IR (νCO bands 
at 2028, 1935 and 1914 cm-1) and NMR spectra showed the 
formation of a cationic species and the formation of an NHC 
ligand. The 13C NMR spectrum shows three signals for the CO 
ligands, reflecting the lack of symmetry, and a low intensity 
doublet at 174.6 ppm characteristic of the carbene carbon bonded 
to the Re atom and coupled to the cis-phosphane ligand (JCP= 11.2 
Hz). The solid state structure of 1b (Figure 1), determined by X-
ray diffraction,[9] confirmed the formation of the NHC ligand, and 
a Re-C2 bond distance (2.198(4) Å) similar to those found for 
previously reported ReI-NHC complexes.[3, 10] 
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Figure 1. Molecular 
structure of the cation of 
1b. 
The reaction of [Re(CO)3(N-MeIm)2(PPh3)]BAr’4 (2) with the 
equimolar amount of KN(SiMe3)2 in THF at -78 ºC led to a 
mixture of unreacted 2 and a new species in a 1:1 ratio. The 
deprotonation of 2 with the potassium amide in a 1:2 
stoichiometry afforded the new species mentioned above, which 
was too unstable to be isolated. Addition of MeOTf (excess) to 
the reactant mixture allowed the isolation of crystals of compound 
2b (see Scheme 2). An X-ray structure determination showed that 
2b is a triflate salt of the cationic binuclear ReI complex which 
molecular structure is showed in Figure 2.[11] 
 
 
 
 
 
 
Figure 2. Molecular structure of the cation of 2b. 
Two different rhenium fragments are bridged by an imidazole 
ligand that has undergone a double activation.[12] The central 
carbon of an N-MeIm ligand, once deprotonated, has attacked the 
carbon atom of a cis-CO (C11), affording a four membered 
metallacycle. A similar  coupling between a CO ligand and a C-
deprotonated, N-coordinated N-alkylimidazole has been recently 
located as an intermediate in the reaction profile transforming an 
N-imidazolyl complex into the more stable C-metal bonded 
tautomer (imidazol-2-yl).[13] The oxygen atom of the involved 
carbonyl (O11) has been methylated leading to the formation of a 
methoxycarbene ligand. The Re1-C11 bond distance, of 2.036(7) 
Å is close to those found for previously known ReI hydroxy- or 
methoxycarbene complexes.[14] Another deprotonation at the 
backbone of the same N-MeIm ligand afforded an abnormal NHC 
ligand bonded to the Re2 atom. In agreement with the higher σ-
donor character of abnormal NHC ligands, the Re2-C5 bond 
distance (2.148(7) Å) is slightly shorter than normal NHC Re-
Ccarbene distances.[3, 10] The coordination of the abnormal NHC 
ligand to Re2 forces the substitution of one carbonyl (C21-O21) 
which is involved in the formation of a new N,N-bidentate ligand 
by its formal coupling with a deprotonated N-MeIm and one N-
MeIm ligands, both coordinated to the Re2 atom. The resulting 
unsaturated oxygen (O21) has been subsequently methylated 
affording a more stable product. 
 
 
 
 
Scheme 2. Reactivity of compounds 2 and 3.  
In the deprotonation and subsequent methylation of 
[Re(CO)3(N-MeIm)2(PPh3)]BAr’4 (2) a minor product, 2c, was 
also isolated by crystallization.[15] As shown in Figure 3, the 
cationic complex of 2c constis of a cis-trans-{Re(CO)2(PPh3)2} 
fragment bonded to a N,N-bidentate chelate. The latter results 
from trapping of CO (displaced by the second phosphane) by the 
two imidazole ligands through a C-C dehydrogenative coupling. 
 
 
 
 
 
 
Figure 3. Molecular 
structure of the cation of 2c. 
Treatment of [Re(CO)3(N-MeIm)2(PMePh2)]BAr’4 (3) with a 
twofold excess of  KN(SiMe3)2 and MeOTf showed the same 
reactivity pattern as that found for 2 leading to the formation of 
3b and 3c, analogous to 2b and 2c respectively (see Supporting 
Information for full experimental details and for the X-ray 
structure of 3b).[16] 
The complex rearrangements involved in the formation of the 
binuclear compounds 2b and 3b, virtually instantaneous at low 
temperature, prompted us to try to isolate an intermediate by 
using a different basic reagent. The addition of the equimolar 
amount of nBuLi to a solution of compound 2 in THF at -78 °C, 
afforded an imidazolyl complex. The formation of a neutral 
complex was clearly evidenced by the νCO bands in the IR 
spectrum (a fac-{Re(CO)3} pattern at 2004, 1906 and 1882 cm-1). 
This species, because of its high instability, was reacted with 
HOTf to afford the NH-NHC complex 2d, which was fully 
characterized including the solid-state structure determined by X-
ray diffraction (Figure 4).[17] 
Strong reactivity differences depending on the base used for 
imidazolium salts deprotonation have been previously noted.[18] 
On the basis of these previous observations the large difference of 
reactivity found in our case could be due to a stabilization of the 
carbene-alkaline-metal adduct when the lithium base is used. 
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Figure 4. Molecular structure of the cation of 2d.  
In summary we have studied the deprotonation reactions of 
[Re(CO)3(N-MeIm)2(PR3)]BAr’4 (1-3) compounds showing that 
the substituent of the phosphane ligand is crucial to determine the 
reactivity pattern. For PMe3complex 1, the product is an imidazol-
2-yl complex that, after methylation, leads to an NHC derivative. 
In contrast, for arylphosphane compounds 2 and 3, an N-
methylimidazole is doubly activated affording binuclear ReI-ReI 
complexes. These unexpected products display several interesting 
features: an abnormal NHC ligand bonded to Re (for the first time 
generated by deprotonation of a coordinated imidazole), the 
formation of a Fischer carbene by CO activation, and the 
substitution of a CO group which is involved in an intramolecular 
ligand coupling. Preliminary studies suggest that the base can be 
non-innocent, and that the choice of the alkaline cation could play 
a role in determining the nature of the product. 
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 S2 
Experimental Section 
All manipulations were performed under an inert atmosphere of nitrogen by using standard Schlenk 
techniques. Dry, oxygen-free solvents were employed. 1H and 13C NMR spectra were recorded on Bruker 
Avance 400 and DPX 300 spectrometers. IR solution spectra were obtained in a Perkin-Elmer FT 1720-X 
spectrometer. Compounds [Re(OTf)(CO)3(N-MeIm)2],[1] and NaBAr´4[2] were prepared following the 
reported procedures. 
Labelling scheme for BAr´: 
B
CF3
CF3
i
o m
p
 
 
Synthesis of [Re(CO)3(N-MeIm)2(PMe3)]BAr´4 (1). A solution of [Re(OTf)(CO)3(N-MeIm)2] (60 mg, 
0.10 mmol), NaBAr´4 (89 mg, 0.10 mmol) and PMe3 (9 µL, 0.10 mmol) in CH2Cl2 (20 mL) was stirred at 
room temperature for 1 h. The reaction mixture was filtered via canula and the solvent was evaporated 
under reduced pressure. Compound 1 was obtained as a white microcrystalline solid that was washed with 
hexane (2 × 15 mL). Yield: 106 mg (77 %). IR (CH2Cl2, cm-1): 2034, 1928, 1912 (νCO).1H NMR 
(CD2Cl2): δ 7.94 (s, 8H, Ho BAr’4), 7.62 (s, 2H, NCHN N-MeIm), 7.59 (s, 4H, Hp BAr’4), 7.00 (m, 2H, 
CH N-MeIm), 6.79 (m, 2H, CH N-MeIm), 3.74 (s, 6H, CH3 N-MeIm), 1.43 (d (J= 8.5 Hz) 9H, CH3 
PMe3).13C{1H}NMR (CD2Cl2): δ 193.3 (2CO), 190.3 (d (JCP= 67.7 Hz) CO), 141.9 (NCHN N-MeIm), 
131.8 (CH N-MeIm), 122.9 (CH N-MeIm), 161.8 (q (J= 49.9 Hz), Ci BAr’4), 134.8 (Co BAr’4), 128.8 (q 
(J= 34.5 Hz), Cm BAr’4), 124.6 (q (J= 272.3 Hz), CF3), 117.5 (Cp BAr’4), 34.6 (CH3 N-MeIm), 15.3 (d 
(JCP= 30.5 Hz), PMe3). 31P {
1
H} NMR (CD2Cl2): δ 32.2. Anal. Calcd. for C46H33BF24N4O3PRe: C 40.22, 
H 2.42, N 4.08. Found: C 40.58, H 2.65, N 3.96. 
 
Synthesis of [Re(CO)3(N-MeIm)2(PPh3)]BAr´4 (2). Compound 2 was prepared as described above for 1 
starting from [Re(OTf)(CO)3(N-MeIm)2] (60 mg, 0.10 mmol), NaBAr´4 (89 mg, 0.10 mmol) and PPh3 (26 
mg, 0.10 mmol). Yield: 126 mg (81 %). IR (CH2Cl2, cm-1): 2036, 1943, 1914 (νCO). 1H NMR (CD2Cl2): δ 
7.74 (s, 8H, Ho BAr’4), 7.59 (s, 4H, Hp BAr’4), 7.42 (m, 15H, PPh3), 6.85 (s, 2H, NCHN N-MeIm), 6.78 
(s, 2H, CH N-MeIm), 6.67 (s, 2H, CH N-MeIm), 3.49 (s, 6H, CH3 N-MeIm). 13C{1H} NMR (CD2Cl2): δ 
194.0 (2CO), 190.2 (CO), 142.2, 135.2, 133.8, 133.7, 130.5, 130.4, 119.5 (PPh3 and N-MeIm), 161.8 (q 
(J= 49.9 Hz), Ci BAr’4), 134.8 (Co BAr’4), 128.8 (q (J= 34.5 Hz), Cm BAr’4), 124.6 (q (J= 272.3 Hz), 
CF3), 117.5 (Cp BAr’4), 35.1 (CH3 N-MeIm). 31P {
1
H} NMR (CD2Cl2): δ 19.9. Anal. Calcd. for 
C61H39BF24N4O3PRe: C 46.97, H 2.52, N 3.59. Found: C 47.21, H 2.31, N 3.72. 
 
Synthesis of [Re(CO)3(N-MeIm)2(PMePh2)]BAr´4 (3). Compound 3 was prepared as described above 
for 1 starting from [Re(OTf)(CO)3(N-MeIm)2] (60 mg, 0.10 mmol), NaBAr´4 (89 mg, 0.10 mmol) and 
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PMePh2 (19 µL, 0.10 mmol). Yield: 139 mg (90 %). IR (CH2Cl2, cm-1): 2031, 1936, 1911 (νCO). 1H NMR 
(CD2Cl2): δ 7.74 (s, 8H, Ho BAr’4), 7.60 (s, 4H, Hp BAr’4), 7.41 (m, 10H, C6H5 PMePh2), 7.06 (s, 2H, 
NCHN N-MeIm) 6.84 (s, 2H, CH N-MeIm), 6.67 (s, 2H, CH N-MeIm), 3.53 (s, 6H, CH3 N-MeIm), 2.15 
(d (J= 7.8 Hz), 3H, CH3 PMePh2). 31P {
1
H} NMR (CD2Cl2): δ -0.9. Anal. Calcd.  for 
C56H37BF24N4O3PRe: C 44.90, H 2.49, N 3.74. Found: C 45.09, H 2.78, N 3.53. 
 
Synthesis of 1a. KN(SiMe3)2 (0.17 mL of a 0.5 M solution in toluene, 0.09 mmol) was added to a 
solution of compound [Re(CO)3(N-MeIm)2(PMe3)]BAr´4 (1) (100 mg, 0.07 mmol) in THF (20 mL) at -78 
ºC. The solution was allowed to reach room temperature, and the resulting yellow solution was 
evaporated under vacuum. The residue was redissolved in CH2Cl2 (20 mL), filtered via canula and the 
solvent was evaporated under reduced pressure to a volume of 5 mL. Addition of hexane caused the 
precipitation of compound 2a as a pale yellow solid, which was washed with hexane (2 × 15 mL) and 
dried under vacuum. Yield: 27 mg (73 %). IR (CH2Cl2, cm-1): 1999, 1899, 1877 (νCO). 1H NMR (CD2Cl2): 
δ 8.63 (s, 1H, NCHN N-MeIm), 7.29 (s, 1H, CH N-MeIm), 6.96 (sbr, 2H, 2 × CH imidazol-2-yl), 6.83 (s, 
1H, CH N-MeIm), 3.80 (s, 3H, CH3), 3.62 (s, 3H, CH3), 1.34 (d (J= 6.9 Hz), 9H, CH3 PMe3). 13C{1H} 
NMR (CD2Cl2): δ 197.6 (d (JCP= 8.4 Hz), CO), 196.4 (d (JCP= 6.9 Hz), CO), 196.3 (d (JCP= 108.1 Hz), 
CO), 171.9 (d (JCP= 13.6 Hz), Re-C), 143.2, 134.3, 121.6, 120.9, 120.6 (N-MeIm and imidazol-2-yl), 
30.1, 34.4 (CH3), 15.5 (d (JCP= 29.9 Hz), CH3 PMe3). 31P NMR {
1
H} (CD2Cl2): δ -29.7. Anal. Calcd for 
C14H20N4O3PRe: C 33.00, H 3.96, N 10.99. Found: C 33.23, H 4.09, N 11.08. 
 
Synthesis of 1b. MeOTf (11 µL, 0.10 mmol) was added to a solution of compound 1a (50 mg, 0.10 
mmol) in CH2Cl2 (20 mL), and the reaction mixture was stirred at room temperature for 5 min. The 
solvent was evaporated under reduced pressure to a volume of 5 mL and addition of hexane (20 mL) 
caused the precipitation of a yellow solid, which was washed with hexane (2 × 20 mL) and dried under 
vacuum. Slow diffusion of hexane (20 mL) into a concentrated solution of 1b in CH2Cl2 at -20 ºC 
afforded yellow crystals, one of which was employed for an X-ray determination. Yield: 49 mg (74 %). 
IR (CH2Cl2, cm-1): 2028, 1935, 1914 (νCO). 1H NMR (CD2Cl2): δ 7.80 (s, 1H, NCHN N-MeIm), 7.17 (sbr, 
2H, 2 × CH NHC), 7.10 (s, 1H, CH N-MeIm), 6.88 (s, 1H, CH N-MeIm) 3.87 (s, 3H, CH3 N-MeIm), 3.61 
(s, 6H, CH3 NHC), 1.53 (d (J= 8.1 Hz), 9H, CH3 PMe3). 13C{1H} NMR (CD2Cl2): δ 193.8 (d (JCP= 7.5 
Hz), CO), 193.0 (d (JCP= 8.9 Hz), CO), 190.7 (d (JCP= 60.3 Hz), CO), 174.6 (d (JCP= 11.2 Hz), Re-C), 
143.0, 133.2, 124.1, 123.7, 120.9 (N-MeIm and NHC), 39.5 (s, 2 × CH3 NHC) 34.4 (CH3 N-MeIm), 34.8 
(d (JCP= 30.4 Hz), CH3 PMe3). 31P {
1
H} NMR (CD2Cl2): δ -36.8. Anal. Calcd. for C16H23F3N4O6PSRe: C 
28.53, H 3.44, N 8.32. Found: C 28.59, H 3.62, N 8.06. 
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Synthesis of 2b. KN(SiMe3)2 (0.60 mL of a 0.5 M solution in toluene, 0.30 mmol) was added to a 
solution of [Re(CO)3(N-MeIm)2(PPh3)]BAr´4 (2) (200 mg, 0.12 mmol) in THF (20 mL) previously cooled 
to -78 ºC. The color of the solution changed immediately from colorless to red, and the solvent was 
evaporated to dryness. The residue was redissolved in CH2Cl2 (20 mL), MeOTf (28 µL, 0.26 mmol) was 
added and the mixture was allowed to stir at room temperature for 15 min. The resulting red solution was 
filtered via canula and the solvent was evaporated under reduced pressure to a volume of 5 mL. Slow 
diffusion of hexane (20 mL) at -20 ºC afforded red crystals, one of which was employed for an X-ray 
determination. Yield: 63 mg (43 %). IR (CH2Cl2, cm-1): 1929, 1907, 1844, 1835 (νCO) 1H NMR (CD2Cl2): 
δ 7.76 (s, 8H, Ho BAr’4), 7.60 (s, 4H, Hp BAr’4), 7.21 (m, 30H, PPh3), 7.03 (s, 1H, CH), 6.99 (s, 1H, CH), 
6.95 (s, 1H, CH), 6.92 (s, 1H, CH), 6.89 (s, 1H, CH), 6.77 (s, 1H, CH), 6.42 (s, 1H, CH), 5.49 (s, 1H, 
CH), 5.20 (s, 1H, CH), 4.52 (s, 3H, OCH3), 4.03 (s, 3H, NCH3), 3.80 (s, 3H, NCH3), 3.60 (s, 3H, NCH3), 
3.32 (s, 3H, NCH3), 2.47 (s, 3H, OCH3). 31P{1H} NMR (CD2Cl2): δ 30.3, 21.5. Anal. Calcd. for 
C92H69BF24N8O6P2Re2: C 48.39, H 3.05, N 4.91. Found: C 49.01, H 3.18, N 4.96. 
 
Synthesis of 2c. Compound 2c was obtained as a minor product in the synthesis of compound 2b. Slow 
diffusion of hexane into a concentrated solution of the mother liquore that afforded 2b at -20 ºC afforded 
pale yellow crystals of 2c. Repetition of the reaction of compound 2 with KN(SiMe3)2, and followed by 
MeOTf afforded both products 2b and 2c in approximately the same ratio. Yield: 12 mg (10 %). IR 
(CH2Cl2, cm-1): 1936, 1865 (νCO). 1H NMR (CD2Cl2): δ 7.74 (s, 8H, Ho BAr’4), 7.57 (s, 4H, Hp BAr’4), 
7.25 (m, 30H, 2PPh3), 6.85 (s, 2H, CH) 6.65 (s, 2H, CH), 3.85 (s, 6H, NCH3) 31P{1H}NMR (CD2Cl2): δ 
20.5. Anal. Calcd. for C79H52BF24N4O3P2Re: C 52.13, H 2.88, N 3.08. Found: C 52.42, H 3.09, N 2.87. 
 
Synthesis of 3b. Compound 3b was prepared as described above for 2b starting from [Re(CO)3(N-
MeIm)2(PMePh2)]BAr´4 (3) (200 mg, 0.14 mmol), KN(SiMe3)2 (0.60 mL of a 0.5 M solution in toluene, 
0.30 mmol) and MeOTf (30 µL, 0.26 mmol). Yield: 64 mg (46 %). IR (CH2Cl2, cm-1): 1929, 1904, 1841, 
1826 (νCO). 1H NMR (CD2Cl2): δ 7.76 (s, 8H, Ho BAr’4), 7.60 (s, 4H, Hp BAr’4), 7.24 (m, 23H, PMePh2 
and 3 × CH), 7.06 (s, 1H, CH), 6.90 (s, 1H, CH), 6.58 (s, 1H, CH), 6.54 (s, 1H, CH), 5.95 (s, 1H, CH), 
5.52 (s, 1H, CH), 4.46 (s, 3H, OCH3), 3.84 (s, 3H, NCH3), 3.79 (s, 3H, NCH3), 3.68 (s, 3H, NCH3), 3.34 
(s, 3H, NCH3), 2.44 (s, 3H, OCH3), 1.95 (d (JHP= 7.3 Hz), 3H, CH3 PMePh2), 1.85 (d (JHP= 6.9 Hz), 3H, 
CH3 PMePh2). 31P{
1
H} NMR (CD2Cl2): δ 10.3, 4.2. Anal. Calcd.  for C82H65BF24N8O6P2Re2: C 45.60, H 
3.03, N 5.19. Found: C 45.45, H 3.33, N 4.98. 
 
Synthesis of 3c. Compound 3c was obtained in the same way as it has been described for 2c. 3c was 
obtained as pale yellow crystals. Yield: 12 mg (11 %). IR (CH2Cl2, cm-1): 1932, 1855 (νCO). 1H NMR 
(CD2Cl2): δ 7.74 (s, 8H, Ho BAr’4), 7.57 (s, 4H, Hp BAr’4), 7.22 (m, 20H, PMePh2), 7.06 (s, 2H, CH) 6.70 
(s, 2H, CH), 3.91 (s, 6H, NCH3), 1.90 (sbr, 6H, CH3 PMePh2). 31P{1H}NMR (CD2Cl2): δ 12.8. Anal. 
Calcd. for C69H48BF24N4O3P2Re: C 48.86, H 2.85, N 3.30. Found: C 48.56, H 3.04, N 3.13. 
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Synthesis of 2d. nBuLi (40 µL of a 1.6 M solution in hexane, 0.06 mmol) was added to a solution of 
compound [Re(CO)3(N-MeIm)2(PPh3)]BAr´4 (2) (100 mg, 0.06 mmol) in THF (20 mL) at -78 ºC. The 
reaction mixture was allowed to reach room temperature and then the solvent was evaporated to dryness. 
The residue was extracted with toluene (20 mL), HOTf was added, and the reaction was stirred for 30 
min. The solvent was concentrated under vacuum to a volume of 5 mL and slow diffusion of hexane (15 
mL) at -20 ºC afforded yellow crystals of 2d, one of which was employed for an X-ray structure 
determination. Yield: 49 mg (74 %). IR (CH2Cl2, cm-1): 2031, 1943, 1917 (νCO). 1H NMR (CD2Cl2): δ 
8.59 (sbr, NH NHC), 7.74 (s, 8H, Ho BAr’4), 7.60 (s, 4H, Hp BAr’4), 7.39 (m, 15H, PPh3) 6.98, 6.94, 6.85, 
6.77, 6.68 (s, 1H each, NCHN and CH N-MeIm and NHC), 3.87, 3.61 (s, 3H each, CH3 N-MeIm and 
NHC). 13C{1H} NMR (CD2Cl2): δ 194.2 (d (JCP= 7.4 Hz), CO), 193.0 (d (JCP= 7.9 Hz), CO), 190.2 (d 
(JCP= 60.0 Hz), CO), 172.0 (d (JCP= 10.1 Hz), Re-C), 161.8 (q (J= 49.9 Hz), Ci BAr’4), 134.8 (Co BAr’4), 
128.8 (q (J= 34.5 Hz), Cm BAr’4), 124.6 (q (J= 272.3 Hz), CF3), 117.5 (Cp BAr’4), 143.4, 133.8, 131.4, 
129.5, 124.0 (N-MeIm and NHC), 39.0, 35.1 (CH3 N-MeIm and NHC). 31P {
1
H} NMR (CD2Cl2): δ 14.6. 
Anal. Calcd. for C61H39BF24N4O3PRe: C 46.97, H 2.52, N 3.59. Found: C 47.34, H 2.66, N 3.43. 
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Crystal Structure Determination. 
 
For Compounds 2b, 2c, and 2b. Data collection was performed at 150(2) K (for 2b) or 100(2) K (for 2c 
and 2d) on a Oxford Diffraction Xcalibur Nova single crystal diffractometer, using Cu-Kα radiation (λ= 
1.5418 Å). Images were collected at a 65 mm fixed crystal-detector distance, using the oscillation method, 
with 1º oscillation and variable exposure time per image (4-16 s). Data collection strategy was calculated 
with the program CrysAlisPro CCD.3 Data reduction and cell refinement was performed with the program 
CrysAlisPro RED.3 An empirical absorption correction was applied using the SCALE3 ABSPACK.3  
For Compounds 2 and 3b. Data collection was performed at 150(2) K on a Nonius KappaCCD single 
crystal diffractometer, using Mo-Kα radiation (λ= 0.71073 Å). Images were collected at a 29 mm fixed 
crystal-detector distance, using the oscillation method, with 2º oscillation and 40 s exposure time per 
image. Data collection strategy was calculated with the program Collect.4 Data reduction and cell 
refinement were performed with the programs HKL Denzo and Scalepack.5 A semi-empirical absorption 
correction was applied using the program SORTAV.6  
For compound 1b. Crystal data were collected on a Bruker APPEX II diffractometer using graphite-
monochromated Mο Kα radiation (λ= 0.71073 Å) from a fine-focus sealed tube source at 150 K. 
Computing data and reduction were made with the APPEX II software.7 In all cases empirical absorption 
corrections were applied using SADABS.8 
Crystal structures were solved by direct methods, using the program SIR-92.9 Anisotropic least-
squares refinement was carried out with SHELXL-97.10  
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Figure S1. Molecular Structure of the cation of compound 2. 
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Table S1. Selected bond distances (Å) and angles (º) of compound 2. 
 
 
Selected Bond Distances (Å) 
 
Re1-C12          1.929(7) N3-C5 1.37(1) 
Re1-C13 1.960(7) C5-N4 1.29(1) 
Re1-C11 1.957(7) N4-C7 1.35(1) 
C11-O11 1.129(8) C7-C6 1.410(1) 
C12-O12 1.154(8) C6-N3 1.37(1) 
C13-O13 1.138(9) N1-C1 1.42(1) 
C18-C17 1.44(39 N1-C2 1.40(1) 
Re1-P1 2.499(2) C1-N2 1.27(1) 
Re1-N1 2.195(6) N2-C3 1.41(2) 
Re1-N3 2.231(6) C3-C2 1.46(2) 
Selected Bond Angles (º) 
 
O12-C12-Re1 177.2(6) C13-Re1-P1 179.0(2) 
O13-C13-Re1 179.2(7) C11-Re1P1 89.8(2) 
O11-C11-Re1 178.4(6) N1-Re1-N3 87.8(3) 
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Figure S2. Molecular Structure of the cation of Compound 3b.  
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 S9 
Table S2. Selected bond distances (Å) and angles (º) of compound 3b. 
 
Selected Bond distances (Å) 
 
Re1-C11 2.070(14) Re2-C20 1.861(16) 
Re1-C12 1.900(14) Re2-C23 1.856(13) 
Re1-C13 1.908(14) Re2-P2 2.415(3) 
Re1-N1 2.287(9) Re2-N22 2-213(9) 
Re1-N2 2.240(12) Re2-N21 2-196(10) 
Re1-P1 2.427(3) Re2-C5 2.169(11) 
N1-C2 1.314(15) C26-C21 1.465(19) 
C4-N1 1.344(16) C22-C21 1.479(18) 
C2-C11 1.389(19) C21-O21 1.423(16) 
C11-O11 1.332(15) O21-C10 1.402(16) 
O11-C1 1.436(15) N22-C27 1.323(17) 
C2-N3 1.373(16) C27-C28 1.352(17) 
C5-C4 1.385(16) C28-N24 1.375(8) 
C5-N3 1.368(15) N24-C26 1.346(16) 
N21-C22 1.331(14) C22-N23 1.386(16) 
N23-C25 1.366(17) C25-C24 1.356(18) 
C24-N21 1.367(16) C26-N22 1.330(15) 
Selected Bond Angles (º) 
 
O11-C11-Re1 141.3(11) C22-C21-C26 112.3(11) 
C2-C11-Re1 97.9(8) C22-C21-O21 105.4(10) 
O11-C11-C2 120.7(13) C26-C21-O21 114.7(12) 
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